Cargando…
CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport
Pancreatic cancer (PC) is featured with low survival rate and poor outcomes. Herein, we found that the expression of caspase-recruitment domain-containing protein 9 (CARD9), predominantly expressed in innate immune cells, was positively related to the prognosis of PC patients. CARD9-deficient PC mic...
Autores principales: | Tian, Cheng, Yuan, Huimin, Lu, Yi, He, Henghui, Li, Qing, Li, Senlin, Yang, Jian, Wang, Mengheng, Xu, Ruochen, Liu, Qian, Xiang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120541/ https://www.ncbi.nlm.nih.gov/pubmed/37089447 http://dx.doi.org/10.1080/2162402X.2023.2204015 |
Ejemplares similares
-
Treatment efficacy of high‐dose creatine supplementation in a child with creatine transporter (SLC6A8) deficiency
por: Shi, Kaili, et al.
Publicado: (2021) -
Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency
por: Skelton, Matthew R., et al.
Publicado: (2011) -
The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome
por: Farr, Clemens V., et al.
Publicado: (2020) -
Creatine transporter (SLC6A8) knockout mice display an increased capacity for in vitro creatine biosynthesis in skeletal muscle
por: Russell, Aaron P., et al.
Publicado: (2014) -
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels
por: Kurth, Isabel, et al.
Publicado: (2021)